Rhona Jane Cox

Person

Leicestershire, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent number 8,722,883
- Issue date May 13, 2014
- Astrazeneca AB
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent number 8,410,123
- Issue date Apr 2, 2013
- Astrazeneca AB
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenoxypyridinylamide compounds
- Patent number 8,273,774
- Issue date Sep 25, 2012
- Astrazeneca AB
- Glen Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent number 8,269,002
- Issue date Sep 18, 2012
- Astrazeneca AB
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine sulphonamide derivatives as chemokine receptor modulators
- Patent number 7,838,675
- Issue date Nov 23, 2010
- Astrazeneca AB
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Publication number 20130203991
- Publication date Aug 8, 2013
- ASTRAZENECA R&D ALDERLY PARK
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Publication number 20130012490
- Publication date Jan 10, 2013
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Publication number 20120157431
- Publication date Jun 21, 2012
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds 637
- Publication number 20120077801
- Publication date Mar 29, 2012
- Roger Victor Bonnert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Publication number 20110124619
- Publication date May 26, 2011
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
- Publication number 20100204203
- Publication date Aug 12, 2010
- Roger Victor Bonnert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds 293
- Publication number 20100041638
- Publication date Feb 18, 2010
- Glen Andrews
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds 637
- Publication number 20090124596
- Publication date May 14, 2009
- Roger Victor Bonnert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS
- Publication number 20090029958
- Publication date Jan 29, 2009
- Lilian Alcaraz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Publication number 20080096860
- Publication date Apr 24, 2008
- AstraZeneca AB
- David Ranulf Cheshire
- C07 - ORGANIC CHEMISTRY

Rhona Jane Cox

Person

Patents Grantslast 30 patents

Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Phenoxypyridinylamide compounds

Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Patents Applicationslast 30 patents

Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators

Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators

Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators

Chemical Compounds 637

Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators

Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors

Chemical Compounds 293

Chemical Compounds 637

PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS

Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators